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In two studies, involving 75 and 72 workers, potential exposure to 3-chloro-4-fluoroaniline (CFA) was biologically monitored by determination of its
main urinary metabolite 2-amino-4-chloro-5-fluorophenol sulfate (CFA-S). As this method only allows the detection of recent exposure, analysis of
CFA adducts bound to hemoglobin (Hb) was investigated as a method that allows biological monitoring of exposure to CFA over longer periods. The
median CFA-S concentration in 67 samples from the first study was 0.14 pmole/g creatinine (range <0.05 - 2.82) and in 201 samples from the second
study 0.21 pmole/g creatinine (range <0.05 - 6.05). In addition, urine samples, collected after shifts with supposed incidental exposure, slightly
higher concentrations were measured: 0.27 pmole/g creatinine (range <0.05 - 122; 18 samples) and 0.76 pmole/g creatinine (range <0.05 - 18.5; 46
samples), respectively. The median Hb adduct concentration in 75 samples from the first study was 9 pmoles CFAIg Hb (range <5 - 640) and in 46
samples from the second study 12 pmoles/g Hb (range 3 - 24). In 24 blood samples collected after incidents, a median concentration of 13 pmoles
CFA/g Hb (range <5 - 52) was found. Urinary CFA-S and Hb adducts correlated well in samples collected shortly after incidental exposures.
However, in 25% of the operators, no CFA-S was detected during routine biological monitoring while Hb adduct analysis showed clear evidence of
exposure. This indicates that because of the stability of Hb adducts of CFA in blood, intermittent exposure to CFA is more reliably biologically moni-
tored by determination of Hb adducts of CFA than by assessment of urinary CFA-S. - Environ Health Perspect 102(Suppl 6):23-25 (1994)
Key words: 3-chloro-4-fluoroaniline, 2-amino-4-chloro-5-fluorophenol sulfate, aromatic amines/arylamines, biological monitoring, hemoglobin
adducts
Introduction
3-Chloro-4-fluoroaniline (CFA) is an inter-
mediate in herbicide manufacture. A major
pathway in the metabolism ofCFA in man
is ring-oxidation to 2-amino-4-chloro-5-
fluorophenol, which is rapidly excreted in
the urine as its sulfate conjugate (CFA-S)
(1). It was estimated in workers exposed to
3 low concentrations of CFA (<0.3 mg/mi
8-hr time-weighted average) that more
than 25% ofthe inhaled CFA is excreted as
CFA-S in urine voided during the shift (NJ
van Sittert, unpublished observations).
Despite the high sensitivity ofthe determi-
nation of CFA-S in urine, the method can
only be used to detect exposure during the
past 24 hr because ofthis rapid elimination.
A minor pathway in the metabolism of
arylamines is N-oxidation to the corre-
sponding hydroxylamine, which may be
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further oxidized in an autocatalytic co-oxida-
tion process with hemoglobin (Hb) yielding
the nitrosoarene (2). The nitrosoarene can
react with the ,B-93 cysteine residue of Hb
to a sulfinic acid amide (Figure 1). Because
Hb adducts are stable in vivo (3), measure-
ment of CFA bound to Hb should, theo-
retically, allow the detection of exposure
over a much longer period (4). In this
study, workers potentially exposed to CFA
were biologically monitored by determina-
tion of both urinary CFA-S and CFA
adducts bound to Hb.
Materials and Methods
Chemicals
CFA-S was obtained from Sittingbourne
Research Center (Shell Research Ltd., UK)
and was >99% pure. All other reagents
were purchased commercially and of the
highest purity.
Biological MonitoringofIndustrial
Workers
All workers potentially exposed to CFA in
the Shell herbicide plant in Pernis are rou-
tinely monitored by determination of uri-
nary CFA-S. The men are employed on a
five-shift system and postshift urine samples
are collected at the end ofevery third night
shift. During herbicide production in 1991
and 1992, the workers also were monitored
by determination of CFA adducts bound
to Hb. For that purpose blood samples
were collected at the end ofeach production
period. The operators also were asked to
provide additional urine samples at the end
of shifts in which incidental exposure to
CFA might have occurred. In 1992, these
samples were analyzed within 24 hr and if
the concentration of CFA-S was higher
than 0.5 pmole/g creatinine, an extra blood
sample was collected the next day for Hb
adduct analysis.
DetenninationofUrinaryCFA-S
The concentration of CFA-S in urine was
determined by HPLC with fluorescence
detection by a method previously developed
in our laboratory (1). To allow correction
for differences in urinary output, the
creatinine (cr) content of the samples was
assessed by the Jaffe method. All results are
expressed as pmole/g cr.
DeterminationofHbAdducts ofCFA
Blood samples were collected by venapunc-
ture from the antecubital vein in 10-ml
heparinized vacuum tubes and centrifuged.
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Figure 1. Oxidative metabolism of 3-chloro-4-fluoroaniline (CFA). (A) CFA is ring oxidized and subsequently sul-
fated to 2-amino-4-chloro-5-fluorophenal (CFA-S) (B), which is excreted into the urine. A minor oxidative pathway
leads, via the hydroxylamine, to the nitrosoarene, which forms hemoglobin adducts through the f-93 cysteine
residue of hemoglobin (C). The sulfinamide bond is hydrolyzed under mild alkaline conditions yielding the original
CFA(A).
The plasma and buffy coat were removed,
and the erythrocytes were washed three
times with 10 ml physiologic saline. The
erythrocytes were then resuspended with
purified water and lysed by subsequent
freezing and thawing. After sedimentation
of membranes, the solution was dialyzed
during 48 hr against purified water, and
the amount of Hb was assessed spectro-
scopically using a Sysmex K-1000 blood
analyzer. After addition of4-chloroaniline
(pCA) as internal standard, aliquots of the
dialysate were hydrolyzed by incubation
with 0.1 M NaOH (final concentration)
during 2 hr at room temperature and pro-
tected from light. The hydrolysates were
prepared for analysis according to Stillwell
et al. (5) with some minor modifications.
Briefly, the CFA was extracted into
dichloromethane (DCM), reacted with
pentafluoropropionic acid anhydride but
without the addition of trimethylamine.
The DCM was evaporated with a gentle
stream of N2 at room temperature. The
residue was dissolved in ethyl acetate by
sonification and after centrifugation the
clear supernatant was analyzed on a
Hewlett Packard 5890 series II gas chro-
matograph equipped with a 5971A mass
selective detector in the electron impact
mode (electron energy fixed at 70 eV, ion
source at 180°C). The GC column was a
60 m x 0.25 mm fused silica capillary,
coated with a 0.1-pm film ofDurabond-1.
Helium was used as carrier gas at a flow of
1 ml/min. One microliter injections were
made using an HP7673 autosampler in the
splitless mode with an injector temperature
of250°C. The initial oven temperature was
600C for 1 min, followed by a temperature
ramp (200/min) to 170°C, another ramp
(10°/min) to 300°C and an isothermal
phase at 3000C for 5 min. The following
ions were monitored with dwell times of
50 ms each: m/z 293 (CFA) and m/z 273
(pCA). Calibration graphs were con-
structed by plotting the ratio of the inte-
grated peak areas of the ions of CFA and
pCA against the ratio ofthe amounts CFA
and pCA in a series of Hb samples pre-
pared from control blood spiked with vary-
ing amounts of CFA and prepared in the
same way as the unknown samples. The
concentration CFA in the unknown sample
was calculated from this graph and divided
by the concentration ofHb in the sample.
Results and Discussion
Recently, a method was developed in our
laboratory that allows quantification of
CFA-S in urine (1). Due to its rapid urinary
elimination, determination of CFA-S only
allows detection ofexposure during the last
24 hr after cessation of exposure. As Hb
adducts of arylamines are thought to be
rather stable in vivo (3), the assessment of
Hb adducts is a promising tool for the bio-
logical monitoring ofarylamines in the case
ofintermittent exposure and chronic expo-
sures to low concentrations. We adapted
the method developed by Stillwell and co-
workers (5) and applied it to workers
potentially exposed to low concentrations
ofCFA. The method was found to be both
specific and sensitive as in persons not
occupationally exposed to CFA, Hb adduct
levels were below the limit of quantifica-
tion, which was less than 5 pmoles/g Hb.
Both methods, determination of CFA-S
in urine and CFA Hb adducts in blood,
were applied during the production of
CFA-based herbicides in 1991 and 1992.
In 1991, 56 operators provided 85 urinary
samples: 67 routine samples and 18 sam-
ples that were collected after incidents that,
in their opinion, might have led to expo-
sure. The median concentration in the rou-
tine samples was 0.14 pmole/g cr (range
<0.05-2.82) and in the incident samples
0.27 pmole/g cr (range <0.05-122). A
blood sample was obtained from 75 opera-
tors. The concentration ofCFA adducts to
Hb ranged from <5 to 640 pmoles CFA/g
Hb (median 9 pmoles CFA/g Hb). In
1992, 201 routine and 46 incident urine
samples were collected from 69 operators.
The median concentration ofCFA-S in the
routine samples was 0.21 pmole/g cr
(range <0.05-6.05). In the incident sam-
ples, the median CFA-S concentration was
0.76 pmole/g cr (range <0.05-18.5).
Forty-six blood samples were collected at
the end ofthe production period. The con-
centration of CFA adducts to Hb ranged
from <5 to 24 pmoles CFA/g Hb (medium
12 pmoles CFA/g Hb). Twenty-two blood
samples were collected after supposed inci-
dental exposure. The median concentration
of adducts in these samples was only 13
pmoles CFA/g Hb (range <5-52).
Twice in 1991 and on 19 occasions in
1992, mostly after a supposed incidental
exposure, a blood sample was collected
within 1 day after the collection of a urine
sample. It appeared that the concentrations
of CFA bound to Hb correlated very well
with the concentration of CFA-S in the
corresponding urine samples (Figure 2).
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Figure 2. Correlation between excretion of 2-amino-
4-chloro-5-fluorophenol in urine and formation of
hemoglobin adducts of 3-chloro-4-fluoroaniline in
workers occupationally exposed to low concentrations
3-chloro-4-fluoroaniline CFA(n = 21, r=0.987).
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In the case ofan accidental exposure in
which an operator spilled some CFA-con-
taining fluid on unprotected skin, an
adduct level of640 pmoles CFA/g Hb was
found. The man provided another blood
sample 20 days later. Assuming first-order
kinetics and that no exposure had occurred
during those 20 days, a half-life for the
adduct of 17 days was calculated for the
disappearance ofthe Hb adduct ofCFA in
blood. Although this is considerably
shorter than expected from the life-span of
the erythrocyte (i.e., 126 days), it is long
enough to allow detection several weeks
after exposure. In 1991, 51 ofthe 56 oper-
ators who provided one or more urine sam-
ples during the production period also
provided a blood sample at the end ofthat
period. In 13 of these 51 operators, no
detectable amount ofCFA-S (i.e., less than
0.05 pmole/g cr) was found in urine while
in all blood samples Hb adducts of CFA
were readily detectable (up to 185 pmole
CFA/g Hb). This confirms that exposure
that has occurred more than one day before
the collection of the urine sample will be
missed by measurement of urinary CFA-S
but mayverywell be detected by a much less
frequent assessment ofHb adducts ofCFA
because ofthe much longer half-life ofthe
latter. From this study, it may therefore be
concluded that the determination of Hb
adducts provides a useful method for the
biologic monitoring ofexposure to low con-
centrations of CFA over prolonged periods
and also for incidental higher exposures.
REFERENCES
1. Eadsforth CV, Coveney PC, Ho A, Sjoe W. An improved analyti-
cal method, based on HPLC with electrochemical detection, for
monitoring exposure to 3-chloro-4-fluoroaniline. J Anal Toxicol
12:330-333 (1988).
2. Neumann HG. Biomonitoring of aromatic amines and alkylating
agents by measuring hemoglobin adducts. Int Arch Occup Environ
Health 61:151-155 (1988).
3. Sabbioni G. Hemoglobin binding of monocyclic aromatic amines:
molecular dosimetry and quantitative structure activity relation-
ships for the N-oxidation. Chem Biol Interact 81:91-117 (1992).
4. Farmer PB, Neumann HG, Henschler D. Estimation ofexposure of
man to substances reacting covalently with macromolecufes. Arch
Toxicol 60:251-260 (1987).
5. Stillwell WG, Bryant MS, WishnokJS. GC/MS analysis ofbiologi-
cally important aromatic amines. Application to human dosimetry.
Biomed Environ Mass Spectrom 14:221-227 (1987).
Volume 102, Supplement 6, October 1994 25